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Eccrine Porocarcinoma: A Case Report of a Rare
Skin Malignancy (Dermatopathologic View)
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Abstract
Eccrine porocarcinoma is extremely rare malignant skin adnexal tumor histogenetically derived from the sweat gland ducts
and acrosyringium. The authors described a 66-year-old woman, who was diagnosed to have a malignant cutaneous
neoplasia arising in the lateral side of the right shin. The lesion displayed exophytic growth with central ulceration, it was
rounded and well-defined having 25 mm in diameter. Microscopically, it exhibited a mixture of atypical basaloid and clear cell
population arranged in solid-nodular fashion, that grew out from the epidermis and infiltrated the corium. Ductal formations
were sporadically present as well. Tumor was immunohistochemically positive for HMWCK, CK7, EMA, weakly positive for
pCEA and negative for mCEA and BerEP4. The spectrum of histomorphologic and immunophenotypic findings favored a
diagnosis of primary eccrine porocarcinoma. Having made the retrospective analysis, the authors found only this single one
biopsy-proven case of EP during the last seven years suggesting exclusive diagnosis in a routine dermatopathologic practice.
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Problem statement and analysis of the
recent research
Skin adnexal tumors (SATs) are rare, but very large and di-
verse group of neoplasms, that may be histopathologically di-
vided into follicular, eccrine, apocrine, sebaceous, and mixed
cathegories [1]. The vast majority of such lesions are benign
and complete surgical excision is usually curative. Conversely,
their malignant counterparts occur only sporadically; however,
they possess a high potential for metastatic spread, with a poor
clinical outcome [1]. Therefore, making a diagnosis of ma-
lignancy in SATs is cardinal for therapeutic and prognostic
purposes. Sweat gland tumors represent approximately 21%
of all SATs; about 14% of such tumors are malignant [2].
Within this latter cathegory, eccrine porocarcinoma (EP, ma-
lignant eccrine poroma) is a unique tumor type accounting
for 1.4% of all sweat gland tumors [2]. Herein, we briefly
present a case being observed in our institution focusing on
dermatopathologic aspects of the disease.
1. Case presentation
A 66-year-old woman was referred by her dermatologist to
the surgical department to remove a progressively growing
skin tumor arising in the lateral side of the right shin. The
patient claimed that the lesion had been present for half a year.
Presumptive clinical diagnoses were pyogenic granuloma, an-
gioma, or angiosarcoma. During physical examination, the
lesion displayed exophytic growth with central ulceration;
it was well-defined, rounded, had 25 mm in diameter, was
gray-brownish in color with focal hemorrhages. Surgical
extirpation was performed and a specimen was sent for micro-
scopic examination. A biopsy sample was immunohistochem-
ically studied using standard hematoxylin and eosin (H&E)
stained paraffin sections. Histology has revealed malignant
adnexal tumor, predominantly with solid-nodular microarchi-
tecture, that grew out from the epidermis and infiltrated deep
corium (Fig. 1, 2). The tumor tissue exhibited a mixture of
poromatous basaloid and clear cell population that displayed
cellular atypia and increased mitotic activity (12 mitoses per
10 high-power field, HPF), including atypic mitotic figures. A
proliferation index (expression of Ki-67 antigen, clone MM1,
Leica) reached 70%. Pagetoid spread of cancer cells in the
adjacent epidermis was focally seen. The ductal formations
were sometimes found as well (Fig. 3). In some areas, a few
interspersed dendritic melanocytes strongly immunoreactive
for S-100 protein (clone 15E2E2, BioGenes) were arranged
within tumor mass. The spectrum of histomorphologic and
immunophenotypic findings favored a diagnosis of primary
eccrine porocarcinoma. Resection margins were free of tumor
and after achievement of the final diagnosis, the patient was
further treated by her dermatologist. No evidence of recur-
rence or metastases has been recorded when preparing this
article.
Eccrine Porocarcinoma: A Case Report of a Rare Skin Malignancy (Dermatopathologic View) — 2/4
Figure 1. Solid tumor nests consisted of a mixture of
basophilic and clear cell population connected to the
epidermis. (H&E, magnification x40).
Figure 2. Focus of atypical basaloid tumor cells growing
out from the epidermis and infiltrating the upper corium.
(H&E, magnification x100).
2. Discussion
EP was first described in 1963 by Pinkus and Mehregan [3].
An old woman developed it as an unusual epidermotropic
form of malignant skin tumor which had finally killed the
patient. Based on the cytologic characteristics and pagetoid
spread of neoplastic cells they stated that the lesion was prob-
ably of eccrine origin. They named it epidermotropic eccrine
carcinoma. Since then, in literature there have been published
numerous case reports [4-11]. Due to the rarity of this onco-
logical entity, accurate data on its incidence, etiopathogenesis,
and biological behaviour are quite poor. It has been reported
that EP encompassed about 0.005 – 0.01% of all cutaneous
malignancies [4]. Recently, however, Italian author Carmelo
Figure 3. Well-formed duct structure within an atypical
clear cell population. (H&E, magnification x200).
Urso has published the article stating that in his department,
among 1,051 patients with malignant skin tumors diagnosed
in 2011, thirty-seven persons had porocarcinoma, representing
3.5% of all cases [12]. It indicated the fact that this neoplasia
might actually be more common than described in literature.
In the context of such unexpectedly high percentage, we at-
tempted to estimate its prevalence in our files. For this pur-
pose, we have retrospectivelly analyzed all cases of cutaneous
malignancies of epithelial and melanocytic origin (including
lesions in situ), which had been diagnosed and registered in
the database of the Department of Pathology during the pe-
riod 2010-2016. During this period, 985 cases of primary
cutaneous malignant tumors had been diagnosed, and only
this case (0.1%) represented EP. Therefore, our results did not
confirm the conclusions published by C. Urso [14] and rather
inclined to the previous literature data [4] demonstrating an
extremely low prevalence.
EP exhibits no special features and it cannot be clinically
distinguish from other common skin tumors [4, 10]. It typi-
cally appears in elderly people in the fifth to seventh decades
of their life [4, 10, 13] with a slight preponderance among
women [4]. The most common location is the lower extremity
[4, 13]. Our case is in accord with those clinical features. EP
is histogenetically derived from the dermal ducts of sweat
glands and acrosyringium [13]. It usually consists of cohesive
nests and islands of predominantly poroid basophilic tumor
cells, that grow out from the epidermis, and (in case of in-
vasive lesion) invade into the dermis and deeper tissue [4,
13, 14]. The signs of ductal differentiation in the form of
either well-formed atypical ducts or inconspicuous intracy-
toplasmic vacuoles are usually seen [4, 13, 14]. However,
the spectrum of histomorphological features may be heteroge-
neous comprising the clear-cell, squamous-cell and spindle-
cell differentiation lines, the presence of cuticular cells with
eosinophilic cytoplasm, mucin-containing cells, or colonized
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Figure 4. Intense immunoreactivity for CK7 in cancer
tissue, sharply contrasting with a CK7-negative epidermis.
Pagetoid spread of the tumor cells within epidermis (antibody
against CK7, magnification x100).
melanocytes [4, 13, 14]. In certain cases, some of these cellu-
lar population may prevail and several specific variants of EP
are defined, such as clear cells, squamous cells, sarcomatoid
cells, pigmented cells and Bowenoid cells [14]. EP displays
varying degrees of cytologic atypia and mitotic activity, al-
though cellular pleomorphism may not be marked and many
lesions present a low-grade appearance. Thus, epithelial cell
atypia itself does not constitute a diagnosis of malignancy
as it may be seen in benign poroma. Under such conditions,
focal infiltrative growth pattern of lesions is more important
for accurate diagnosis [4, 13, 14]. The presence of benign
tumor counterpart (poroma) within EP is a discussed topic, as
there is not clearly elucidated, whether EP arises ab initio, or
via malignant transformation of benign lesion. In a consecu-
tive series of 69 cases of EP [4], a benign tumor component
occured only in 18% of cases. In contrast, Swan et al. [7]
stated that all 27 cases of EP in their series arose alonside
with benign poroma. Nevertheless, the popular belief is that
the vast majority of EP arise de novo [13]. In our case, no
benign-appearing tumor component was histologically seen.
Biological behaviour and clinical outcome of EP are hardly
predictible. The original study series have demonstrated lo-
cal recurrences in 4.1-35% [4-7, 10, 11] and metastases in
4.1–50% of cases [4-10]. Despite marked percentage variance,
these data suggest that EP is likely an aggressive and prognos-
tically unfavorable type of cutaneous neoplasia. Therefore, it
is crucial to define those histologic parameters that may pro-
vide a guide to the prognosis. According to Robson et al. [4],
the following four histopathologic features are the most im-
portant prognosticators: a) lymphovascular invasion; b) tumor
thickness ¿7 mm; c) more than 14 mitoses per 10 HPF; d) the
infiltrative growth pattern. However, the reliability of these
variables remains debatable, since, for instance, Kurashige
et al. [5] did not observe their relationships with prognosis
in eight studied patients. A majority of cases displayed the
infiltrative growth pattern and the given depth of invasion
was considered to be predictive of recurrence or metastasis.
Another authors [10] have reported two histopathologic crite-
ria were significantly associated with a metastatic outcome:
scattered pattern of the dermal invasive component and tumor
thickness above 10 mm. Similarly, Belin et al. [11] have
found that the recurrence risk was associated with the infil-
trative and pagetoid growth pattern of tumor. On this basis
it may be postulated that among the main histopathologic
parameters, the growth pattern seems to be prognostically the
most important in EP. Therefore, it should be always noted in
biopsy reports.
3. Conclusions
Our experience showed that EP is exclusive when diagnosing
in routine dermatopathologic practice. Due to recent data con-
firming that EP exhibits an aggressive biological behaviour,
all patients suffered from this neoplasia require an accurate
clinical follow-up.
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